Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is pleased to announce the Emergency Use Authorization of QUANTA Flash.

SARS-CoV-2 IgG by the US Food and Drug Administration (FDA) for use on BIO-FLASH® random access ...

Moderna has announced that initial data from its Phase II study shows that a single 50µg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titre responses against SARS-CoV-2 and two variants of concern, B.1.351 (first ...

Standard Bariatrics® announced today that its novel Titan SGS™ stapling technology, designed specifically for bariatric sleeve surgery, has been cleared by the US Food and Drug Administration (FDA).

1 The Titan SGS™ first-of-its-kind design offers surgeons performing sleeve gastrectomy ...

Orange Photonics is pleased to announce that the LightLab 3 Cannabis Analyzer now reports Delta-8 THC (D8-THC), an increasingly popular cannabinoid found in hemp-derived cannabis products.

In addition, Orange Photonics is releasing a new Mobile Monitoring feature which gives users the ability ...

The Specialty Hospital, Amman, Jordan, today announced it is the first hospital within the MENA region to adopt the innovative geko™ device for Venous Thromboembolism (VTE) prevention in high-risk vascular patients, unable to be prescribed standard of care.

VTE is a serious complication for ...

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program for the development of a Melanoma antitumor targeting medicine. The announcement comes amidst the recent completion ...